Evaluation of anti-tumor activity of molybdenum disulfide nanoflowers per se and in combination with berberine against mammary gland cancer in rats
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanomaterials for catalytic reactions · Metal complexes synthesis and properties · Enzyme function and inhibition
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (90)
Show source-provided references
1. Fahad Ullah M (2019) Breast Cancer: Current Perspectives on the Disease Status. In: Ahmad A (ed) Breast Cancer Metastasis and Drug Resistance. Advances in Experimental Medicine and Biology, vol 1152. Springer, Cham. https://doi.org/10.1007/978-3-030-20301-6_410.1007/978-3-030-20301-6_4 ↗
2. Eivazzadeh-Keihan R et al (2021) Functionalized magnetic nanoparticles for the separation and purification of proteins and peptides. TrAC, Trends Anal Chem 141:11629110.1016/j.trac.2021.116291 ↗
3. Shamsi U et al (2021) Factors associated with mammographic breast density among women in Karachi Pakistan. BMC Womens Health 21(1):1–1110.1186/s12905-021-01538-4 ↗
4. Al Awar S et al (2020) Prevalence, knowledge, attitude and practices of female genital mutilation and cutting (FGM/C) among United Arab Emirates population. BMC Womens Health 20(1):1–1210.1186/s12905-020-00949-z ↗
5. Prusty RK et al (2020) Knowledge of symptoms and risk factors of breast cancer among women: a community based study in a low socio-economic area of Mumbai. India BMC women’s health 20:1–1210.1186/s12905-019-0871-6 ↗
6. Gavrilovic IT, Posner JB (2005) Brain metastases: epidemiology and pathophysiology. J Neurooncol 75:5–1410.1007/s11060-004-8093-6 ↗
7. Mahdavi M et al (2019) Hereditary breast cancer; genetic penetrance and current status with BRCA. J Cell Physiol 234(5):5741–575010.1002/jcp.27464 ↗
8. Hecht F et al (2016) The role of oxidative stress on breast cancer development and therapy. Tumor biology 37:4281–429110.1007/s13277-016-4873-9 ↗
9. Wallace DC (1999) Mitochondrial diseases in man and mouse. Science 283(5407):1482–148810.1126/science.283.5407.1482 ↗
10. Newmeyer DD, Ferguson-Miller S (2003) Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112(4):481–49010.1016/S0092-8674(03)00116-8 ↗
11. Hsu C-C, Tseng L-M, Lee H-C (2016) Role of mitochondrial dysfunction in cancer progression. Exp Biol Med 241(12):1281–129510.1177/1535370216641787 ↗
12. Hung, W.-Y., et al (2010) Somatic mutations in mitochondrial genome and their potential roles in the progression of human gastric cancer. Biochim et Biophys Acta (BBA)-Gen Subj 1800(3): 264–27010.1016/j.bbagen.2009.06.006 ↗
13. Skulachev VP (1994) Chemiosmotic concept of the membrane bioenergetics: what is already clear and what is still waiting for elucidation? J Bioenerg Biomembr 26:589–59810.1007/BF00831533 ↗
14. Mandavilli BS, Santos JH, Van Houten B (2002) Mitochondrial DNA repair and aging. Mutat Res Fundam Mol Mech Mutagen 509(1–2):127–15110.1016/S0027-5107(02)00220-8 ↗
15. Assi HA et al (2013) Epidemiology and prognosis of breast cancer in young women. J Thorac Dis 5(Suppl 1):S2
16. Waks AG et al (2019) The immune microenvironment in hormone receptor–positive breast cancer before and after preoperative chemotherapyimmune microenvironment in HR+ breast cancer. Clin Cancer Res 25(15):4644–465510.1158/1078-0432.CCR-19-0173 ↗
17. McDonald ES et al (2016) Clinical diagnosis and management of breast cancer. J Nucl Med 57(Supplement 1):9S-16S10.2967/jnumed.115.157834 ↗
18. Geyer C et al (2022) Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trial. Ann Oncol 33(4):384–39410.1016/j.annonc.2022.01.009 ↗
19. Kalal BS, Upadhya D, Pai VR (2017) Chemotherapy resistance mechanisms in advanced skin cancer. Oncol Rev 11(1):326
20. Luo B, Lee AS (2013) The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies. Oncogene 32(7):805–81810.1038/onc.2012.130 ↗
21. Williams HD et al (2013) Strategies to address low drug solubility in discovery and development. Pharmacol Rev 65(1):315–49910.1124/pr.112.005660 ↗
22. Hu C-MJ, Zhang L (2009) Therapeutic nanoparticles to combat cancer drug resistance. Curr Drug Metab 10(8):836–84110.2174/138920009790274540 ↗
23. Niu S et al (2021) Hollow mesoporous silica nanoparticles gated by chitosan-copper sulfide composites as theranostic agents for the treatment of breast cancer. Acta Biomater 126:408–42010.1016/j.actbio.2021.03.024 ↗
24. Negahdary M, Heli H (2018) Applications of nanoflowers in biomedicine. Recent Pat Nanotechnol 12(1):22–3310.2174/1872210511666170911153428 ↗
25. Odularu AT, Ajibade PA, Mbese JZ (2019) Impact of molybdenum compounds as anticancer agents. Bioinorg Chem Appl 2019(1):6416198
26. Mijatović S et al (2020) The double-faced role of nitric oxide and reactive oxygen species in solid tumors. Antioxidants 9(5):37410.3390/antiox9050374 ↗
27. Wang X et al (2023) Influence of polycrystalline MoS2 nanoflowers on mouse breast cancer cell proliferation via molten salt sintering. Arab J Chem 16(4):10459610.1016/j.arabjc.2023.104596 ↗
28. Anh Tran T et al (2014) Toxicity of nano molybdenum trioxide toward invasive breast cancer cells. ACS Appl Mater Interfaces 6(4):2980–298610.1021/am405586d ↗
29. Karnam KC et al (2017) Preventive effect of berberine against DMBA-induced breast cancer in female Sprague Dawley rats. Biomed Pharmacother 92:207–21410.1016/j.biopha.2017.05.069 ↗
30. Cui HM et al (2015) Poor permeability and absorption affect the activity of four alkaloids from Coptis. Mol Med Rep 12(5):7160–716810.3892/mmr.2015.4288 ↗
31. Kohn W, Sham LJ (1965) Self-consistent equations including exchange and correlation effects. Phys Rev 140(4A):A113310.1103/PhysRev.140.A1133 ↗
32. Giannozzi P et al (2009) QUANTUM ESPRESSO: a modular and open-source software project for quantum simulations of materials. J Phys: Condens Matter 21(39):395502
33. Troullier N, Martins JL (1991) Efficient pseudopotentials for plane-wave calculations. Phys Rev B 43(3):199310.1103/PhysRevB.43.1993 ↗
34. Perdew JP, Burke K, Ernzerhof M (1998) Perdew, burke, and ernzerhof reply. Phys Rev Lett 80(4):89110.1103/PhysRevLett.80.891 ↗
35. Monkhorst HJ, Pack JD (1976) Special points for Brillouin-zone integrations. Phys Rev B 13(12):518810.1103/PhysRevB.13.5188 ↗
36. Tkatchenko A, Scheffler M (2009) Accurate molecular van der Waals interactions from ground-state electron density and free-atom reference data. Phys Rev Lett 102(7):07300510.1103/PhysRevLett.102.073005 ↗
37. Líška J et al (2016) Relationship between histology, development and tumorigenesis of mammary gland in female rat. Exp Anim 65(1):1–910.1538/expanim.15-0055 ↗
38. Classics Lowry O et al (1951) Protein measurement with the Folin phenol reagent. J biol Chem 193(1):265–27510.1016/S0021-9258(19)52451-6 ↗
39. Yu W et al (2022) Reactive oxygen species bridge the gap between chronic inflammation and tumor development. Oxid Med Cell Longev 2022(1):2606928
40. Hira S et al (2019) β-Carotene: a natural compound improves cognitive impairment and oxidative stress in a mouse model of streptozotocin-induced Alzheimer’s disease. Biomolecules 9(9):44110.3390/biom9090441 ↗
41. Saxena P et al (2022) Superoxide dismutase as multipotent therapeutic antioxidant enzyme: Role in human diseases. Biotechnol Lett 44:1–2210.1007/s10529-021-03200-3 ↗
42. Kim J-B, Kopalli SR, Koppula S (2016) Cuminum cyminum Linn (Apiaceae) extract attenuates MPTP-induced oxidative stress and behavioral impairments in mouse model of Parkinson’s disease. Trop J Pharm Res 15(4):765–77210.4314/tjpr.v15i4.14 ↗
43. Mintz J et al (2021) Current advances of nitric oxide in cancer and anticancer therapeutics. Vaccines 9(2):9410.3390/vaccines9020094 ↗
44. Bais S, Gill N, Kumar N (2015) Neuroprotective effect of Juniperus communis on chlorpromazine induced Parkinson disease in animal model. Chinese J Biol 2015(1):542542
45. Sciuto AM (2017) Antioxidant properties of glutathione and its role in tissue protection. Oxidants, antioxidants and free radicals. CRC Press, pp 171–19110.1201/9780203744673-9 ↗
46. Adefisan A, Owumi S, Adaramoye O (2019) Root bark extract of Calliandra portoricensis (Jacq.) Benth. chemoprevents N-methyl-N-nitrosourea-induced mammary gland toxicity in rats. J Ethnopharmacol 233:22–3310.1016/j.jep.2018.12.027 ↗
47. Klaunig JE (2018) Oxidative stress and cancer. Curr Pharm Des 24(40):4771–477810.2174/1381612825666190215121712 ↗
48. Draper H et al (1993) A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radical Biol Med 15(4):353–36310.1016/0891-5849(93)90035-S ↗
49. Ruiz-Iglesias A, Mañes S (2021) The importance of mitochondrial pyruvate carrier in cancer cell metabolism and tumorigenesis. Cancers 13(7):148810.3390/cancers13071488 ↗
50. Spinazzi M et al (2012) Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. Nat Protoc 7(6):1235–124610.1038/nprot.2012.058 ↗
51. Aranda-Gutierrez A, Diaz-Perez HM (2023) Histology, mammary glands. StatPearls Publishing, Treasure Island (FL), p 31613512
52. Chen J et al (2021) N-doped MoS2-nanoflowers as peroxidase-like nanozymes for total antioxidant capacity assay. Anal Chim Acta 1180:33874010.1016/j.aca.2021.338740 ↗
53. Panigrahi PK, Pathak A (2011) A novel route for the synthesis of nanotubes and fullerene-like nanostructures of molybdenum disulfide. Mater Res Bull 46(12):2240–224610.1016/j.materresbull.2011.09.003 ↗
54. Lee C et al (2010) Anomalous lattice vibrations of single-and few-layer MoS2. ACS Nano 4(5):2695–270010.1021/nn1003937 ↗
55. Tongay S et al (2012) Magnetic properties of MoS 2: existence of ferromagnetism. Appl Phys Lett 101(12):12310510.1063/1.4753797 ↗
56. Liu X et al (2017) Highly effective degradation of p-nitrophenol over MoS 2 under visible light illumination. Catal Lett 147:2153–215910.1007/s10562-017-2113-6 ↗
57. Meng X et al (2017) MoS2 quantum dots-interspersed Bi2WO6 heterostructures for visible light-induced detoxification and disinfection. Appl Catal B 210:160–17210.1016/j.apcatb.2017.02.083 ↗
58. Gu C et al (2016) Preparation of three-dimensional nanosheet-based molybdenum disulfide nanotubes as anode materials for lithium storage. J Mater Chem A 4(43):17000–1700810.1039/C6TA06689E ↗
59. Hossain MA et al (2018) Electrochemical deposition of bulk MoS2 thin films for photovoltaic applications. Sol Energy Mater Sol Cells 186:165–17410.1016/j.solmat.2018.06.026 ↗
60. Luo L et al (2019) Hydrothermal synthesis of MoS2 with controllable morphologies and its adsorption properties for bisphenol A. J Saudi Chem Soc 23(6):762–77310.1016/j.jscs.2019.01.005 ↗
61. Li B et al (2017) Preparation of monolayer MoS2 quantum dots using temporally shaped femtosecond laser ablation of bulk MoS2 targets in water. Sci Rep 7(1):1118210.1038/s41598-017-10632-3 ↗
62. Manuraj M et al (2020) High performance supercapacitors based on MoS2 nanostructures with near commercial mass loading. J Alloy Compd 819:15296310.1016/j.jallcom.2019.152963 ↗
63. Rahman AU, Rahman G, García-Suárez VM (2017) Development of spontaneous magnetism and half-metallicity in monolayer MoS2. J Magn Magn Mater 443:343–35110.1016/j.jmmm.2017.07.042 ↗
64. Rahman AU et al (2019) Robust ferromagnetism and half-metallicity in hydrogenated monolayer-CdS. Physica B 570:209–21610.1016/j.physb.2019.06.012 ↗
65. Rahman AU et al (2018) Commensurate versus incommensurate heterostructures of group-III monochalcogenides. Phys Rev Mater 2(9):09400210.1103/PhysRevMaterials.2.094002 ↗
66. Barzegar E et al (2015) Effects of berberine on proliferation, cell cycle distribution and apoptosis of human breast cancer T47D and MCF7 cell lines. Iran J Basic Med Sci 18(4):334–342
67. Gold JM, Raja A (2019) Cisplatin. StatPearls Publishing, Treasure Island (FL)
68. Habtemariam S (2020) Recent advances in berberine inspired anticancer approaches: from drug combination to novel formulation technology and derivatization. Molecules 25(6):142610.3390/molecules25061426 ↗
69. Letašiová S et al (2005) Antiproliferative activity of berberine in vitro and in vivo. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149(2):461–46310.5507/bp.2005.080 ↗
70. Sahu A, Varma M, Kachhawa K (2015) A prognostic study of MDA, SOD and catalase in breast cancer patients. Int J Sci Res 4(5):157–159
71. Portakal O et al (2000) Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clin Biochem 33(4):279–28410.1016/S0009-9120(00)00067-9 ↗
72. Hussain S, Ashafaq M (2018) Oxidative stress and anti-oxidants in pre and post-operative cases of breast carcinoma. Turkish Journal of Pharmaceutical Sciences 15(3):354
73. Pompella A et al (2003) The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 66(8):1499–150310.1016/S0006-2952(03)00504-5 ↗
74. Vidhya N, Devaraj SN (2011) Induction of apoptosis by eugenol in human breast cancer cells. Indian J Exp Biol 49:871–878
75. Russo J, Russo IH (2006) The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 102(1–5):89–9610.1016/j.jsbmb.2006.09.004 ↗
76. Colditz GA (1998) Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. JNCI J Natl Cancer Inst 90(11):814–82310.1093/jnci/90.11.814 ↗
77. Mohammed H et al (2015) Progesterone receptor modulates ERα action in breast cancer. Nature 523(7560):313–31710.1038/nature14583 ↗
78. Trabert B et al (2020) Progesterone and breast cancer. Endocr Rev 41(2):320–34410.1210/endrev/bnz001 ↗
79. Bagheri F et al (2014) Stable overexpression of DNA fragmentation factor in T-47D cells: sensitization of breast cancer cells to apoptosis in response to acetazolamide and sulfabenzamide. Mol Biol Rep 41:7387–739410.1007/s11033-014-3626-3 ↗
80. Chen K et al (2022) Mitochondrial mutations and mitoepigenetics: focus on regulation of oxidative stress-induced responses in breast cancers. in Seminars in Cancer Biology, vol 83. Elsevier, pp 556–569
81. Tan D-J, Bai R-K, Wong L-JC (2002) Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Can Res 62(4):972–976
82. Bonora E et al (2006) Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III. Can Res 66(12):6087–609610.1158/0008-5472.CAN-06-0171 ↗
83. Santidrian AF et al (2013) Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. J Clin Investig 123(3):1068–108110.1172/JCI64264 ↗
84. Schapira A et al (1990) Mitochondrial complex I deficiency in Parkinson’s disease. J Neurochem 54(3):823–82710.1111/j.1471-4159.1990.tb02325.x ↗
85. Dalla Pozza E et al (2020) Regulation of succinate dehydrogenase and role of succinate in cancer. in Seminars in cell & developmental biology, vol 98. Elsevier, pp 4–14
86. Cai Z et al (2020) Aberrant expression of citrate synthase is linked to disease progression and clinical outcome in prostate cancer. Cancer Manag Res 12:614910.2147/CMAR.S255817 ↗
87. Schlichtholz B et al (2005) Enhanced citrate synthase activity in human pancreatic cancer. Pancreas 30(2):99–10410.1097/01.mpa.0000153326.69816.7d ↗
88. Tayyab Imtiaz M et al (2021) Triazine derivative as putative candidate for the reduction of hormone-positive breast tumor: in silico, pharmacological, and toxicological approach. Front Pharmacology 126710.3389/fphar.2021.686614 ↗
89. Liu M et al (2021) Functionalized MoS2-based nanomaterials for cancer phototherapy and other biomedical applications. ACS Mater Lett 3(5):462–49610.1021/acsmaterialslett.1c00073 ↗
90. Almatroodi SA, Alsahli MA, Rahmani AH (2022) Berberine: an important emphasis on its anticancer effects through modulation of various cell signaling pathways. Molecules 27(18):588910.3390/molecules27185889 ↗